Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/17/2003US20030073726 Heterocyclic inhibitors of glycine transporter 2
04/17/2003US20030073725 Naphtalene derivatives and their pharmaceutical use
04/17/2003US20030073724 Central nervous system disorders
04/17/2003US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens
04/17/2003US20030073720 Tryptase inhibitors
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073717 Therapy for nervous system disorders; anxiolytic agents; anticonvulsants
04/17/2003US20030073716 Therapy for drug abruse; side effect reduction
04/17/2003US20030073715 Nasal administering; side effect reduction
04/17/2003US20030073714 Prevent drug abruse; side effect reduction; administering mixture of opioid antagonist, releasable form and sequestering agent
04/17/2003US20030073713 Inhibitors of ABC drug transporters at the blood-brain barrier
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073711 Administering enzyme inhibitor; side effect reduction
04/17/2003US20030073708 Compounds specific to adenosine A3 receptor and uses thereof
04/17/2003US20030073707 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
04/17/2003US20030073705 Method of treatment
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073703 Autoimmune disease; antiinflammatory agents
04/17/2003US20030073702 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/17/2003US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production
04/17/2003US20030073700 Central nervous system disorders; Parkinson's disease, Huntington's disease; psycological disorders
04/17/2003US20030073699 Compounds and methods to treat cardiac failure and other disorders
04/17/2003US20030073698 Nitrogen-based camptothecin derivatives
04/17/2003US20030073695 Methods of use of gemifloxacin compounds against fluoroquinolone resistant Streptococcus pneumoniae bacteria
04/17/2003US20030073694 Topical applying to eyes; side effect reduction
04/17/2003US20030073693 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/17/2003US20030073691 Antitumor agents; anticancer agents
04/17/2003US20030073690 Controlling pain in mammals
04/17/2003US20030073688 Novel substituted benzoxazines as integrin antagonists
04/17/2003US20030073686 Anticarcinogenic agents
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy
04/17/2003US20030073683 Administration of noncompetitive AMPA receptor antagonist for neuroprotection after traumatic brain injury
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073680 Therapy for Tay-sach, Gaucher diseases
04/17/2003US20030073678 Vanadium compounds for treating cancer
04/17/2003US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives
04/17/2003US20030073676 Dissolving in aqueous carrier; antiallergens
04/17/2003US20030073675 Novel 19-norsteroids substituted in position 11beta, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them
04/17/2003US20030073674 Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers
04/17/2003US20030073673 Hormonal contraceptive product
04/17/2003US20030073672 Method for treating allergies using substituted pyrazoles
04/17/2003US20030073671 Side effect reduction; hormone replacement therapy
04/17/2003US20030073670 Aqueous solution
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073667 Solvent system containing mixture of terpene and alkylene glycol ethers
04/17/2003US20030073665 Formulations containing propofol and a sulfoalkyl ether cyclodextrin
04/17/2003US20030073663 Water soluble films, sponges, gels
04/17/2003US20030073660 Anticancer agents; blood disorders
04/17/2003US20030073656 Using a tyrosine kinase receptor inhibitor
04/17/2003US20030073654 Stabilized transient gene expression
04/17/2003US20030073653 Method for transferring nucleic acid into striated muscles
04/17/2003US20030073651 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
04/17/2003US20030073649 Administering adenosine deaminase inhibitor
04/17/2003US20030073648 Crystaline clindamycin free base
04/17/2003US20030073647 Crystaline clindamycin free base
04/17/2003US20030073646 Synergistic mixture containing bactericide, fungicide and nitroindazole
04/17/2003US20030073645 Synergistic mixture; antidiabetic agents
04/17/2003US20030073643 D-Mannose contraceptives
04/17/2003US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering
04/17/2003US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy
04/17/2003US20030073617 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
04/17/2003US20030073615 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
04/17/2003US20030073614 Methods for affecting various diseases utilizing LXR compounds
04/17/2003US20030073612 Calibrating polymorphism of human genome; therapy for skin disorders
04/17/2003US20030073611 Detoxification of cells, tissues
04/17/2003US20030073609 Enhanced pharmacokinetic profile of intradermally delivered substances
04/17/2003US20030073608 Alzheimer's disease; administering neurotransmitter antagonist
04/17/2003US20030073592 Removal of protein residues before sterilization
04/17/2003US20030073223 For use in vaccines
04/17/2003US20030073221 Hyaluronan synthase gene and uses thereof
04/17/2003US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073132 Detecting modulators of brain membrane protein; obtain membrane protein, incubate with ligand and labeled compound, measure level of binding
04/17/2003US20030073131 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders
04/17/2003US20030073123 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition
04/17/2003US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development
04/17/2003US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator
04/17/2003US20030072858 Oil composition
04/17/2003US20030072841 Polybutene containing chewing gum and confection
04/17/2003US20030072828 Natural therapeutic composition for the treatment of wounds and sores
04/17/2003US20030072825 Intratumoral use of dinitrochorobenzene: composition and use of injections including particular applications
04/17/2003US20030072824 Having anti-oxidant, gastric mucosa injury inhibiting, aldose reductase inhibiting, blood glucose level elevation inhibiting action, platelet agglutination accelerating action, alcohol absorption inhibition, anti-inflammation properties
04/17/2003US20030072823 For increasing glutathione and antioxidant and antitoxin levels to achieve and maintain a health
04/17/2003US20030072821 Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
04/17/2003US20030072819 Compositions and methods for enhancing drug delivery
04/17/2003US20030072814 Topical pharmaceutical composition for the treatment of warts
04/17/2003US20030072813 Administering formulation comprising Eclipta prostrata L., Angelica dahurica, Polygonum multiforum Thumb, Astragalus complanatus, Tribulus terrestris L., Lithospermum erythrorhizon sieb et zucc Paris petiolata
04/17/2003US20030072809 Introducing a mixture of medicament and excipients comprising crystalline cellulose into high speed agitation granulator and spraying on water or a mixture of ethanol and water as binder solution to produce spherical granule
04/17/2003US20030072808 Immediate release eplerenone compositions
04/17/2003US20030072807 Solid particulate antifungal compositions for pharmaceutical use
04/17/2003US20030072806 Antifungal formulation for therapy of fungal infection of the skin
04/17/2003US20030072804 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
04/17/2003US20030072802 For therapy of mania and depression
04/17/2003US20030072801 Pharmaceutical compositions comprising drug and concentration-enhancing polymers
04/17/2003US20030072800 Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation
04/17/2003US20030072797 Pharmaceutical compositions for oral administration
04/17/2003US20030072792 Drug delivery
1 ... 5498 5499 5500 5501 5502 5503 5504 5505 5506 5507 5508 5509 5510 5511 5512 5513 5514 5515 5516 5517 5518 ... 7860